Search
Search Results
##search.searchResults.foundPlural##
-
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1451PDF: 964HTML: 1306fig 1A: 238figure1B: 203 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2174PDF: 872HTML: 1235 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2370PDF: 904HTML: 977Patient’s family tree: 235 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2771PDF: 883HTML: 388Figure 1: 228 -
Acquired Hemophilia A successfully treated with rituximab
2281PDF: 1215HTML: 1523Figure 1: 243 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1333PDF: 850HTML: 416 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1963PDF: 907HTML: 1662 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1379PDF: 1025HTML: 111 -
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1731PDF: 1140HTML: 499 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1116PDF: 424HTML: 256 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1425PDF: 1122HTML: 451 -
-
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1108PDF: 1305HTML: 139 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3778PDF: 2636HTML: 1679 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3973PDF: 1766HTML: 11940Figures Haase: 281 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2793PDF: 1010HTML: 602 -
The diagnostic pitfalls of mucormycosis
1057PDF: 775HTML: 304 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
2224Suppl. Files: 968HTML: 603PDF: 842 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4293PDF: 1073HTML: 19265 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1401PDF: 921HTML: 276 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4251PDF: 2068HTML: 287 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1670PDF: 903HTML: 1089Picture 1: 217 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3548PDF: 1336HTML: 8404 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1271PDF: 814HTML: 1541Figure 1: 257Figure 2: 261 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2659PDF: 1797HTML: 709







